educational-resources

EDUCATIONAL RESOURCES

DOWNLOADABLE EDUCATIONAL RESOURCES - in 18 languages

How to prevent 9 different cancers & genital warts

Are you due for your cervical screening? Learn about the HPV test.

Poster also available in

French, Greek, Hungarian, Italian, German, Hindi

CANADA'S ROLE IN THE ELIMINATION OF CERVICAL CANCER

Canada is uniquely positioned to be a major contributor to this important effort. In 2019, a group of experts developed a report with 105 recommendations for implementation of actions both in Canada and internationally to reach the following targets:

(AVAILABLE IN FRENCH)

  • 90% of girls fully vaccinated with the HPV vaccine by 15 years of age;
  • 90% of women screened with an HPV test; and
  • 90% of women who are identified with cervical disease receive treatment and care.
  • Long-term Study of a Quadrivalent Human Papillomavirus Vaccine. Read Document
  • What is the responsibility of the national government with respect to vaccination? Read Document

THE HPV VACCINES

  • An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)† 2021-10-21. Read Document
  • THE MISINFORMATION WEB: Learn How to Find and Trust Online Information about HPV Immunization. Read Document
  • HPV vaccination: for women of all ages? Read Document
  • Rebuttal: Do you approve of spending $300 million on HPV Vaccination?- Dr. Marc Steben says yes. Read Document
  • Financial Incentives for Increasing Uptake of HPV Vaccinations: A Randomized Controlled Trial. Read Document,
  • Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study. Read Document
  • Valuing Vaccination. Read Document
  • Immunization against HPV in girls with intellectual disabilities. Read Document
  • Early effects of human papillomavirus vaccination in Belgium. Read Document
  • Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer.
  • The age of distribution of type-specific high-risk human papillomavirus incidence in two population-based screening trials. Read Document
  • Sex Differences Among College Students in Awareness of the HPV Vaccine and Vaccine Options. Read Document
  • Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programs. Read Document
  • Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers. Read Document
  • Health Canada approves CERVARIX™, new GSK cervical cancer vaccine. Read Document
  • Product Monograph, Cervarix®[Human Papillomavirus vaccine Types 16 and 18 (Recombinant, AS04 adjuvanted)] Suspension for injection, Active Immunizing Agent. ATC code: J07BM02. Read Document
  • Product Monograph, Gardasil® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] Suspension for injection, Active Immunizing Agent. Read Document
  • Part III: Consumer Information, Gardasil® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine]. Read Document
  • Product Monograph, Gardasil® 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Suspension for injection, Active Immunizing Agent. Read Document
  • Part III: Consumer Information, Gardasil® 9 [Human Papillomavirus 9-valent Vaccine, Recombinant]. Read Document
  • Beta-Test Results for an HPV Information Website: GoHealthyGirls.org- Increasing HPV Vaccine Uptake in the United States. Read Document
  • Estimation of Geographic Variation in Human Papillomavirus Vaccine Uptake in Men and Women: An Online Survey Using Facebook Recruitment. Read Document

HPV VACCINE SAFETY INFORMATION

  • Healer of Cancer: The Power of the Mind, by Dr. Christian Boukaram. Read Document
  • The HPV Vaccine Controversy, by Shobha S. Krishnan, M.D. Read Document
  • The Early Benefits of Human Papillomavirus Vaccination on Cervical Dysplasia and Anogenital Warts. Read Document
  • Beliefs, behaviours and HPV vaccine: Correcting the myths and the misinformation. Read Document
  • Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of phase 3, double-blind, randomized controlled VIVIANE study. Read Document
  • The Politics of HPV Vaccination Advocacy: Effects of Source Expertise on Effectiveness of a Pro-Vaccine Message. Read Document
  • Human Papillomavirus Vaccine Knowledge and Attitudes, Preventative Health Behaviours, and Medical Mistrust Among a Racially and Ethnically Diverse Sample of College Women. Read Document
  • Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescent and young adults. Read Document

HPV-RELATED, OTHER GYNAECOLOGICAL CANCERS AND DISEASES

  • Are twenty human papillomavirus types causing cervical cancer? Read Document
  • Human Papillomavirus and Related Diseases in Canada. Summary Report 2015-03-20. Read Document
  • Implementation Science in Cancer Prevention and Control: A framework for research and programs in low and middle-income countries. Read Document
  • Otolaryngology-Head and Neck Surgery. Read Document

SCHOOL-BASED VACCINATION

  • Including males in Canadian human papillomavirus vaccination programs: a policy analysis. Read Document
  • Indications for the HPV vaccine in adolescents: A review of the literature. Read Document
  • Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study. Read Document
  • Adverse events following immunization in Ontario’s female school-based HPV program. Read Document
  • Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario Grade 8 HPV Vaccine Cohort Study. Read Document

SEXUAL HEALTH

  • Sex Is Like Jelly Beans: Educating Students on the Risks of Oral Sex. Read Document
  • A risk for non-sexual transmission of human papillomavirus? Read Document